Fondaparinux sodium | CAS 114870-03-0

Product Description

Fondaparinux sodium, also known as CAS 114870-03-0, is an excellent choice for those looking for an effective pharmaceutical intermediate. This product offers numerous advantages such as its ability to reduce the risk of deep vein thrombosis, pulmonary embolism, and sudden cardiac death. It is also highly recommended for use in knee and hip replacement surgeries. With its unique features and functions, fondaparinux sodium makes a valuable addition to any pharmaceutical manufacturing process. Its efficacy in reducing the risk of heart attacks and stroke makes it an ideal choice for those in need of preventative care. In summary, Fondaparinux sodium is an essential product in our industry, with unmatched benefits that will ultimately improve patient outcomes.

Product Features

• Fondaparinux sodium, represented by CAS 114870-03-0.
• An anticoagulant medication used to prevent and treat deep vein thrombosis and pulmonary embolism.
• Highly purified and low molecular weight substance.
• Each batch is extensively tested to ensure consistent quality and reliable performance.

Application of 114870 03 0

• Prevention and treatment of blood clots in patients with deep vein thrombosis or pulmonary embolism
• Prevention of blood clots in patients undergoing surgery or with a history of heparin-induced thrombocytopenia
• Treatment of acute coronary syndrome, including unstable angina and non-ST-elevation myocardial infarction
• Used in combination with aspirin for prevention of blood clots in patients with acute coronary syndrome

Package and shipping

Usually, we sell products with original packages but also be instructed by the customer

Transportation: instructed by the customer. Please contact us for shipping details